v3.26.1
SEGMENT AND GEOGRAPHIC INFORMATION (Tables)
 3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information
Net sales and profit by each reportable segment for the three months ended March 31, 2026 and 2025 are as follows:
Three Months Ended March 31, 2026
Dollars in thousandsSpecialty SurgeryTissue ReconstructionCorporate and OtherTotal
Total revenue, net$283,135 $108,783 $— $391,918 
Cost of goods sold110,475 37,459 27,002 174,936 
Research and development11,853 7,532 4,116 23,501 
Selling, general & administrative77,681 43,526 57,028 178,235 
Intangible asset amortization— — 3,776 3,776 
Total cost and expenses200,009 88,517 91,922 380,448 
Operating income (loss)$83,126 $20,266 $(91,922)11,470 
Interest income4,106 
Interest expense(22,465)
Other income, net4,480 
Loss before income taxes$(2,409)
Three Months Ended March 31, 2025
Dollars in thousandsSpecialty SurgeryTissue ReconstructionCorporate and OtherTotal
Total revenue, net$280,664 $101,989 $— $382,653 
Cost of goods sold (1)
109,861 49,270 29,090 188,221 
Research and development (1)
14,795 5,972 3,961 24,728 
Selling, general & administrative (1)
83,787 42,304 55,406 181,497 
Intangible asset amortization— — 3,704 3,704 
Total cost and expenses208,443 97,546 92,161 398,150 
Operating income (loss)$72,221 $4,443 $(92,161)(15,497)
Interest income4,420 
Interest expense(18,815)
Other income, net(144)
Loss before income taxes$(30,036)
(1) The amounts reported for the three months ended March 31, 2025 have been retrospectively recast to reflect the realignment of certain cost and expense information as discussed in Note 1. Basis of Presentation.
Schedule of Geographic Revenue, by Area Total revenue by major geographic area consisted of the following:
 Three Months Ended March 31,
Dollars in thousands20262025
United States$289,380 $282,217 
Europe39,962 35,326 
Asia Pacific45,212 45,105 
Rest of World17,364 20,005 
Total Revenues$391,918 $382,653